BACKGROUND AND OBJECTIVES: A multidisciplinary team (MDT) approach to chronic kidney disease (CKD) may help optimize care of CKD and comorbidities. We implemented an MDT quality improvement project for persons with stage 3 CKD and comorbid diabetes and/or hypertension. Our objective was to decrease the rate of decline of GFR. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We used a 4-year historical cohort to compare 1769 persons referred for usual nephrology care versus 233 referred for MDT care within an integrated, not-for-profit Health Maintenance Organization (HMO). Usual care consisted of referral to an outside nephrologist. The MDT consisted of an HMO-based nephrologist, pharmacy specialist, diabetes educator, dietitian, social worker, and nephrology nurse. Both groups received usual primary care. The primary outcome was rate of decline of GFR. Secondary outcomes were LDL, hemoglobin A1c, and BP. RESULTS: In multivariate repeated-measures analyses, MDT care was associated with a mean annual decline in GFR of 1.2 versus 2.5 ml/min per 1.73 m(2) for usual care. In stratified analyses, the significant difference in GFR decline persisted only in those who completed their referrals. There were no differences in the secondary outcomes between groups. CONCLUSIONS: In this integrated care setting, MDT care resulted in a slower decline in GFR than usual care. This occurred despite a lack of significant differences for secondary disease-specific measures, suggesting that other differences in the MDT population or care process accounted for the slower decline in GFR in the MDT group.
BACKGROUND AND OBJECTIVES: A multidisciplinary team (MDT) approach to chronic kidney disease (CKD) may help optimize care of CKD and comorbidities. We implemented an MDT quality improvement project for persons with stage 3 CKD and comorbid diabetes and/or hypertension. Our objective was to decrease the rate of decline of GFR. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We used a 4-year historical cohort to compare 1769 persons referred for usual nephrology care versus 233 referred for MDT care within an integrated, not-for-profit Health Maintenance Organization (HMO). Usual care consisted of referral to an outside nephrologist. The MDT consisted of an HMO-based nephrologist, pharmacy specialist, diabetes educator, dietitian, social worker, and nephrology nurse. Both groups received usual primary care. The primary outcome was rate of decline of GFR. Secondary outcomes were LDL, hemoglobin A1c, and BP. RESULTS: In multivariate repeated-measures analyses, MDT care was associated with a mean annual decline in GFR of 1.2 versus 2.5 ml/min per 1.73 m(2) for usual care. In stratified analyses, the significant difference in GFR decline persisted only in those who completed their referrals. There were no differences in the secondary outcomes between groups. CONCLUSIONS: In this integrated care setting, MDT care resulted in a slower decline in GFR than usual care. This occurred despite a lack of significant differences for secondary disease-specific measures, suggesting that other differences in the MDT population or care process accounted for the slower decline in GFR in the MDT group.
Authors: Allen R Nissenson; Allan J Collins; Judith Hurley; Hans Petersen; Brian J G Pereira; Earl P Steinberg Journal: J Am Soc Nephrol Date: 2001-08 Impact factor: 10.121
Authors: Manjula Kurella-Tamura; Benjamin A Goldstein; Yoshio N Hall; Aya A Mitani; Wolfgang C Winkelmayer Journal: J Am Soc Nephrol Date: 2014-03-20 Impact factor: 10.121
Authors: Denise M Hynes; Michael Fischer; Marian Fitzgibbon; Anna C Porter; Michael Berbaum; Linda Schiffer; Ifeanyi B Chukwudozie; Hai Nguyen; Jose Arruda Journal: J Gen Intern Med Date: 2019-07-24 Impact factor: 5.128
Authors: Martin Fortin; Maud-Christine Chouinard; Marie-France Dubois; Martin Bélanger; José Almirall; Tarek Bouhali; Maxime Sasseville Journal: CMAJ Open Date: 2016-10-12
Authors: Ifeanyi Beverly Chukwudozie; Marian L Fitzgibbon; Linda Schiffer; Michael Berbaum; Cheryl Gilmartin; Pyone David; Eson Ekpo; Michael J Fischer; Anna C Porter; Alana Aziz-Bradley; Denise M Hynes Journal: Transl Behav Med Date: 2018-05-23 Impact factor: 3.046
Authors: Anna C Porter; Marian L Fitzgibbon; Michael J Fischer; Rani Gallardo; Michael L Berbaum; James P Lash; Sheila Castillo; Linda Schiffer; Lisa K Sharp; John Tulley; Jose A Arruda; Denise M Hynes Journal: Contemp Clin Trials Date: 2015-02-28 Impact factor: 2.226
Authors: Varun Agrawal; Bernard G Jaar; Xenia Y Frisby; Shu-Cheng Chen; Yang Qiu; Suying Li; Adam T Whaley-Connell; Peter A McCullough; Andrew S Bomback Journal: Am J Kidney Dis Date: 2012-03 Impact factor: 8.860
Authors: Rupert W Major; Celia Brown; David Shepherd; Stephen Rogers; Warren Pickering; Graham L Warwick; Shaun Barber; Nuzhat B Ashra; Tom Morris; Nigel J Brunskill Journal: J Am Soc Nephrol Date: 2019-05-16 Impact factor: 10.121
Authors: Claudine T Jurkovitz; Daniel Elliott; Suying Li; Georges Saab; Andrew S Bomback; Keith C Norris; Shu-Cheng Chen; Peter A McCullough; Adam T Whaley-Connell Journal: Am J Kidney Dis Date: 2012-03 Impact factor: 8.860